Bone mineral density in elderly men and women: results from the Framingham osteoporosis study.

The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2006) 2.24

Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups. Am J Hum Genet (2009) 2.14

Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int (2005) 1.82

Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ (1994) 1.51

Gene-gene interaction between RBMS3 and ZNF516 influences bone mineral density. J Bone Miner Res (2013) 1.45

Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosis. PLoS Genet (2010) 1.41

Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr (2011) 1.26

Dietary intakes of arachidonic acid and alpha-linolenic acid are associated with reduced risk of hip fracture in older adults. J Nutr (2011) 1.15

Lean mass and not fat mass is associated with male proximal femur strength. J Bone Miner Res (2008) 1.13

Height loss predicts subsequent hip fracture in men and women of the Framingham Study. J Bone Miner Res (2012) 1.09

Hip structural geometry in old and old-old age: similarities and differences between men and women. Bone (2007) 1.06

Contributions of lean mass and fat mass to bone mineral density: a study in postmenopausal women. BMC Musculoskelet Disord (2010) 1.04

Bone mineral density reference norms for Hong Kong Chinese. Osteoporos Int (2005) 1.00

Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies. Curr Osteoporos Rep (2012) 0.99

Inverse association of carotenoid intakes with 4-y change in bone mineral density in elderly men and women: the Framingham Osteoporosis Study. Am J Clin Nutr (2008) 0.98

Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European men. Osteoporos Int (2010) 0.94

Bone mineral density at the hip in Norwegian women and men--prevalence of osteoporosis depends on chosen references: the Tromsø Study. Eur J Epidemiol (2009) 0.93

Limited utility of clinical indices for the prediction of symptomatic fracture risk in postmenopausal women. Osteoporos Int (2003) 0.92

Endogenous sex steroids, weight change and rates of hip bone loss in older men: the MrOS study. Osteoporos Int (2006) 0.92

IL21R and PTH may underlie variation of femoral neck bone mineral density as revealed by a genome-wide association study. J Bone Miner Res (2010) 0.92

High vitamin C intake is associated with lower 4-year bone loss in elderly men. J Nutr (2008) 0.91

Validation of an osteoporosis self-assessment tool to identify primary osteoporosis and new osteoporotic vertebral fractures in postmenopausal Chinese women in Beijing. BMC Musculoskelet Disord (2013) 0.90

Correlates of trabecular and cortical volumetric BMD in men of African ancestry. J Bone Miner Res (2009) 0.87

Plasma phosphatidylcholine concentrations of polyunsaturated fatty acids are differentially associated with hip bone mineral density and hip fracture in older adults: the Framingham Osteoporosis Study. J Bone Miner Res (2012) 0.86

The factor-of-risk biomechanical approach predicts hip fracture in men and women: the Framingham Study. Osteoporos Int (2011) 0.84

Hip bone geometry in HIV/HCV-co-infected men and healthy controls. Osteoporos Int (2011) 0.83

Palmitic acid and DGAT1 deficiency enhance osteoclastogenesis, while oleic acid-induced triglyceride formation prevents it. J Bone Miner Res (2014) 0.83

Importance of fat mass and lean mass on bone health in men: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV). Osteoporos Int (2013) 0.82

An assessment of the use of quantitative ultrasound and the Osteoporosis Self-Assessment Tool for Asians in determining the risk of nonvertebral fracture in postmenopausal Chinese women. J Bone Miner Metab (2008) 0.82

Assessment of determinants for osteoporosis in elderly men. Osteoporos Int (2008) 0.82

Multigenerational impact of maternal overnutrition/obesity in the sheep on the neonatal leptin surge in granddaughters. Int J Obes (Lond) (2014) 0.82

Background for studies on the treatment of male osteoporosis: state of the art. Ann Rheum Dis (2000) 0.80

Associates of bone mineral density in older African Americans. J Natl Med Assoc (2004) 0.79

Dairy Intake Is Protective against Bone Loss in Older Vitamin D Supplement Users: The Framingham Study. J Nutr (2017) 0.78

Forearm bone mineral density in an unselected population of 2,779 men and women--the HUNT Study, Norway. Osteoporos Int (2004) 0.78

Disentangling the body weight-bone mineral density association among breast cancer survivors: an examination of the independent roles of lean mass and fat mass. BMC Cancer (2013) 0.77

A biomechanical sorting of clinical risk factors affecting osteoporotic hip fracture. Osteoporos Int (2015) 0.77

Low dietary calcium and obesity: a comparative study in genetically obese and normal rats during early growth. Eur J Nutr (2013) 0.76

A concise review of testosterone and bone health. Clin Interv Aging (2016) 0.76

A Mediterranean Diet to Improve Cardiovascular and Cognitive Health: Protocol for a Randomised Controlled Intervention Study. Nutrients (2017) 0.75

Bone turnover predicts change in volumetric bone density and bone geometry at the radius in men. Osteoporos Int (2016) 0.75

Relationship of bone mineral density with valvular and annular calcification in community-dwelling older people: The Cardiovascular Health Study. Arch Osteoporos (2017) 0.75

Effect sizes for interpreting changes in health status. Med Care (1989) 15.39

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum (1995) 15.00

Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum (1998) 12.36

The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum (1987) 9.24

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum (1993) 8.73

The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38

The role of knee alignment in disease progression and functional decline in knee osteoarthritis. JAMA (2001) 7.15

Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA (2000) 6.54

Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med (1988) 6.36

Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work. Am J Epidemiol (1988) 6.34

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet (2001) 6.23

Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum (1997) 5.57

Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med (1992) 5.05

A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med (1994) 5.04

Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum (2001) 4.57

AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum (1992) 4.08

The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med (1993) 4.04

OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage (2004) 4.01

Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med (1997) 3.96

Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum (1995) 3.89

Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol (2000) 3.63

The association of meniscal pathologic changes with cartilage loss in symptomatic knee osteoarthritis. Arthritis Rheum (2006) 3.51

Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res (1993) 3.31

Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res (2000) 3.09

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med (1987) 3.00

Is obesity a risk factor for progressive radiographic knee osteoarthritis? Arthritis Rheum (2009) 2.92

Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum (2000) 2.92

Change in joint space width: hyaline articular cartilage loss or alteration in meniscus? Arthritis Rheum (2006) 2.80

Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology (1999) 2.69

Laxity in healthy and osteoarthritic knees. Arthritis Rheum (1999) 2.68

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. Arthritis Rheum (1990) 2.67

Knee effusions, popliteal cysts, and synovial thickening: association with knee pain in osteoarthritis. J Rheumatol (2001) 2.59

ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology. J Rheumatol (1999) 2.58

Comparison of the prevalence of knee osteoarthritis between the elderly Chinese population in Beijing and whites in the United States: The Beijing Osteoarthritis Study. Arthritis Rheum (2001) 2.45

Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis. Ann Rheum Dis (2008) 2.27

Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann Intern Med (1996) 2.24

World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl (1994) 2.23

Prevalence of foot and ankle conditions in a multiethnic community sample of older adults. Am J Epidemiol (2004) 2.20

Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample. Am J Clin Nutr (1997) 2.18

Obesity and mortality in the Lipid Research Clinics Program Follow-up Study. J Clin Epidemiol (1990) 2.16

The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum (1994) 2.06

Mapping of two loci affecting the regulation of branched-chain amino acid transport in Escherichia coli K-12. J Bacteriol (1976) 2.04

Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med (2000) 2.02

Impaired vision and hip fracture. The Framingham Study. J Am Geriatr Soc (1989) 1.97

Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: the Framingham Study. J Rheumatol (2000) 1.94

Effect of dietary protein on bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res (2000) 1.94

Body fat and skeletal muscle mass in relation to physical disability in very old men and women of the Framingham Heart Study. J Gerontol A Biol Sci Med Sci (1998) 1.92

The efficacy of home based progressive strength training in older adults with knee osteoarthritis: a randomized controlled trial. J Rheumatol (2001) 1.88

Which traditional measures should be used in rheumatoid arthritis clinical trials? Arthritis Rheum (1989) 1.85

Intakes of calcium, phosphorus, and protein, and physical-activity level are related to radial bone mass in young adult women. Am J Clin Nutr (1993) 1.84

Level of physical activity and the risk of radiographic and symptomatic knee osteoarthritis in the elderly: the Framingham study. Am J Med (1999) 1.83

Caffeine and the risk of hip fracture: the Framingham Study. Am J Epidemiol (1990) 1.81

Defining radiographic osteoarthritis for the whole knee. Osteoarthritis Cartilage (1997) 1.80

The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study. J Rheumatol (1989) 1.80

Deriving a risk-adjustment model for pressure ulcer development using the Minimum Data Set. J Am Geriatr Soc (2001) 1.78

Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene (1995) 1.69

Catabolism of aromatic acids in Trichosporon cutaneum. J Bacteriol (1980) 1.69

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med (1993) 1.68

Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nat Med (1996) 1.68

Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience (2003) 1.65

Effect of meniscal damage on the development of frequent knee pain, aching, or stiffness. Arthritis Rheum (2007) 1.64

Musculoskeletal disease research: should we analyze the joint or the person? J Rheumatol (1996) 1.63

Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet (1987) 1.63

Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent? Arthritis Rheum (1998) 1.62

The effect of alendronate on progression of spinal osteophytes and disc-space narrowing. Ann Rheum Dis (2008) 1.61

Defining arthritis and measuring functional status in elders: methodological issues in the study of disease and physical disability. Am J Public Health (1990) 1.58

Structural and functional analysis of cloned DNA containing genes responsible for branched-chain amino acid transport in Escherichia coli. Proc Natl Acad Sci U S A (1980) 1.57

Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum (1996) 1.56

Time for changes in the design, analysis, and reporting of rheumatoid arthritis clinical trials. Arthritis Rheum (1990) 1.56

Quadriceps weakness predicts risk for knee joint space narrowing in women in the MOST cohort. Osteoarthritis Cartilage (2010) 1.56

Amino-terminal sequence and processing of the precursor of the leucine-specific binding protein, and evidence for conformational differences between the precursor and the mature form. Proc Natl Acad Sci U S A (1980) 1.56

Escherichia coli transport mutants lacking binding protein and other components of the branched-chain amino acid transport systems. J Bacteriol (1977) 1.55

Relation of synovitis to knee pain using contrast-enhanced MRIs. Ann Rheum Dis (2010) 1.55

Ethnic and genetic differences in bone mass: a review with a hereditary vs environmental perspective. Am J Clin Nutr (1989) 1.54

The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach. Arthritis Rheum (1999) 1.50

Bone mineral density and knee osteoarthritis in elderly men and women. The Framingham Study. Arthritis Rheum (1993) 1.48

A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum (1986) 1.48

Patient preferences for treatment of rheumatoid arthritis. Ann Rheum Dis (2004) 1.47

The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration. Arthritis Rheum (1985) 1.46

Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study. Arthritis Care Res (Hoboken) (2012) 1.40

In vivo cartilage contact deformation in the healthy human tibiofemoral joint. Rheumatology (Oxford) (2008) 1.39

Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials. Arthritis Rheum (1992) 1.39

The rapid assessment of disease activity in rheumatology (radar) questionnaire. Validity and sensitivity to change of a patient self-report measure of joint count and clinical status. Arthritis Rheum (1992) 1.39

The effect of a teaching skills course on interns' and students' evaluations of their resident--teachers. Acad Med (1999) 1.38

Survival of patients with primary (AL) amyloidosis. Colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973). Am J Med (1987) 1.37

Measurement of growth and iron deposition in Sphaerotilus discophorus. J Bacteriol (1976) 1.36

Blinding images to sequence in osteoarthritis: evidence from other diseases. Osteoarthritis Cartilage (2008) 1.34

Evaluating diagnosis-based case-mix measures: how well do they apply to the VA population? Med Care (2001) 1.33

The association of meniscal damage with joint effusion in persons without radiographic osteoarthritis: the Framingham and MOST osteoarthritis studies. Osteoarthritis Cartilage (2008) 1.33

The association of bone attrition with knee pain and other MRI features of osteoarthritis. Ann Rheum Dis (2008) 1.33

Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor. J Pharmacol Exp Ther (2004) 1.32

Subchondral bone marrow lesions are highly associated with, and predict subchondral bone attrition longitudinally: the MOST study. Osteoarthritis Cartilage (2009) 1.29